Qui Vivra Verra
reacted to
29
11
7
Qui Vivra Verra
reacted to
$LumiraDx (LMDXF.US)$ it seems every time I look at th3 comments something new or something was done or this might happen or whatever. I'm learning not to look at the comments anymore. . and just wait. been waiting since feb. last year. the same story with different titles. 250,000 shares. it is what it is. everyone should has been making money in other stock, I place way over 100 stock to go in and out snice Feb.. do t no what to tell no body about this stock. I'm just waiting ...
5
1
Qui Vivra Verra
reacted to
$ImmunityBio (IBRX.US)$ I shoulda just not said anything. Seems i let them know where i was?? Hehehe. 🖕🫵🩳🐀s! LMAO
3
9
Qui Vivra Verra
commented on
$Aclarion (ACON.US)$ But with volume about to hit 190 million already and its back below .05! Well i kinda can guess what’s happening here! Hehehe. And will say REFORMS are needed! Hehehe
3
31
Qui Vivra Verra
liked
STOCK TRADING 101: PART D
FDA FILINGS
Biotech companies undergo a rigorous FDA (U.S. Food and Drug Administration) filing and approval process before bringing new drugs or treatments to market. These filings provide critical information for stock traders, as approval milestones can significantly impact a company’s stock price. Here’s an overview of key FDA filings, their purposes, and timelines:
1. Investigational New Drug (IND) Application
...
FDA FILINGS
Biotech companies undergo a rigorous FDA (U.S. Food and Drug Administration) filing and approval process before bringing new drugs or treatments to market. These filings provide critical information for stock traders, as approval milestones can significantly impact a company’s stock price. Here’s an overview of key FDA filings, their purposes, and timelines:
1. Investigational New Drug (IND) Application
...
13
1
10